🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 5 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 03/04/2013 | 60,30 | 60,30 | 59,34 | 59,89 | -0,33% | 1,59% | 843.900 |
| 02/04/2013 | 60,34 | 60,46 | 59,94 | 60,09 | +0,08% | 0,86% | 645.000 |
| 01/04/2013 | 60,87 | 61,31 | 59,94 | 60,04 | -1,36% | 2,25% | 669.800 |
| 28/03/2013 | 61,12 | 61,69 | 60,62 | 60,87 | -0,54% | 1,75% | 414.700 |
| 27/03/2013 | 60,10 | 61,48 | 59,99 | 61,20 | +1,34% | 2,48% | 706.700 |
| 26/03/2013 | 59,92 | 60,56 | 59,59 | 60,39 | +1,29% | 1,62% | 657.900 |
| 25/03/2013 | 58,43 | 60,21 | 56,85 | 59,62 | -2,18% | 5,75% | 3.407.100 |
| 22/03/2013 | 61,02 | 61,44 | 60,55 | 60,95 | -0,07% | 1,46% | 827.500 |
| 21/03/2013 | 62,41 | 62,71 | 60,91 | 60,99 | -2,53% | 2,88% | 954.100 |
| 20/03/2013 | 62,43 | 63,11 | 62,35 | 62,57 | +0,53% | 1,22% | 488.100 |
| 19/03/2013 | 62,00 | 62,45 | 61,85 | 62,24 | +0,60% | 0,97% | 639.200 |
| 18/03/2013 | 60,95 | 62,46 | 60,46 | 61,87 | +1,33% | 3,28% | 657.200 |
| 15/03/2013 | 61,94 | 62,27 | 61,02 | 61,06 | -1,36% | 2,02% | 1.183.700 |
| 14/03/2013 | 62,10 | 62,35 | 61,65 | 61,90 | -0,23% | 1,13% | 981.500 |
| 13/03/2013 | 62,70 | 62,82 | 61,80 | 62,04 | -0,72% | 1,63% | 1.276.800 |
| 12/03/2013 | 62,08 | 62,61 | 61,74 | 62,49 | +0,64% | 1,40% | 967.400 |
| 11/03/2013 | 61,75 | 62,24 | 61,49 | 62,09 | +0,58% | 1,21% | 648.200 |
| 08/03/2013 | 61,61 | 62,10 | 61,00 | 61,73 | +0,65% | 1,79% | 1.299.300 |
| 07/03/2013 | 61,44 | 61,87 | 61,01 | 61,33 | +0,00% | 1,40% | 544.900 |
| 06/03/2013 | 61,82 | 61,93 | 61,09 | 61,33 | -0,11% | 1,36% | 1.169.000 |
| 05/03/2013 | 61,15 | 61,54 | 60,92 | 61,40 | +0,79% | 1,01% | 1.437.100 |
| 04/03/2013 | 60,93 | 60,98 | 60,15 | 60,92 | +0,18% | 1,36% | 643.100 |
| 01/03/2013 | 59,67 | 60,95 | 59,15 | 60,81 | +1,67% | 3,02% | 969.200 |
| 28/02/2013 | 59,04 | 60,26 | 59,04 | 59,81 | +1,05% | 2,07% | 770.100 |
| 27/02/2013 | 58,21 | 59,57 | 58,03 | 59,19 | +1,70% | 2,65% | 522.500 |
| 26/02/2013 | 58,04 | 58,50 | 56,80 | 58,20 | +0,94% | 2,93% | 820.800 |
| 25/02/2013 | 58,12 | 58,51 | 57,62 | 57,66 | -0,16% | 1,53% | 866.300 |
| 22/02/2013 | 57,05 | 57,85 | 56,73 | 57,75 | +1,40% | 1,96% | 417.600 |
| 21/02/2013 | 56,30 | 57,33 | 55,89 | 56,95 | +1,21% | 2,56% | 726.600 |
| 20/02/2013 | 56,81 | 57,36 | 56,24 | 56,27 | -1,04% | 1,97% | 636.900 |